跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROFLUMILAST AUROVITAS 250 MICROGRAMOS COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROFLUMILAST AUROVITAS 250 MICROGRAMOS COMPRIMIDOS EFG
Approved
STANDARD
ROFLUMILAST AUROVITAS 250 MICROGRAMOS COMPRIMIDOS EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 7, 2024
Approval ID
0c6c2fd0e04143a3
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
0c6c2fd0e04143a3
Drug Cima Aemps Name
ROFLUMILAST AUROVITAS 250 MICROGRAMOS COMPRIMIDOS EFG
Register Number
89830
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2024-10-07
Dosage Form
COMPRIMIDO
Dose
250 microgramos
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
ROFLUMILAST
0,25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 7, 2024
Approval ID
0c6c2fd0e04143a3
Type
Standard
Back to CIMA-AEMPS Approvals
